Avecia Tunes in to 'pPop'TM Gene Expression System
Developed through strategic R&D within AstraZeneca (former owner of Avecia’s predecessor, Zeneca Specialties), ‘pPOP’™ technology adds to Avecia’s already strong know-how in process creation, process development and GMP manufacturing of E.coli and yeast-derived protein therapeutics for biotechnology and pharmaceutical customers.
Avecia Biotechnology’s R&D Manager Dr. Mark Carver commented: “Our new 'pPOP’™ technology is a tightly regulated but fully inducible expression system. A unique feature is that the production rate of a desired protein product can be directly modulated by the concentration of inducer, added during fermentation”.
This feature allows the protein product production rate to be 'tuned' to match the protein and its site of accumulation (intracellular as inclusion bodies, soluble or secretion into the periplasm) within the microbial cell. This provides a ‘generic’ E.coli expression system. ‘pPOP’™ also has the advantages of being both growth medium and host strain independent.
Dr Carver concluded: “Avecia’s focus on seeking improvements in process productivity for recombinant protein therapeutics through innovative technology will continue to team in-house inventions with complementary in-licensing of leading methods”.
The ‘pPOP’™ development is the latest in a series to boost Avecia Biotechnology’s gene expression tool kit. In May, Avecia announced that it had licensed the patented bacterial cell expression technology of XOMA Ltd. for use by its Biologics contract development and manufacturing business at Billingham.
Most read news
Topics
Organizations
Other news from the department research and development
Get the chemical industry in your inbox
From now on, don't miss a thing: Our newsletter for the chemical industry, analytics, lab technology and process engineering brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.